Funnelfeedr Logo

Sixera Pharma AB

Sverige556901-4763Active

Small biotech developing first treatment for rare Netherton syndrome.

Biopharmaceutical Companysixerapharma.com

Oversigt

1–4
Medarbejdere
≤1t SEK
Omsætning
2012
Grundlagt

Nøglebeslutningstagere

Hans Olivecrona

Chief Medical Officer

Margit Mahlapuu

Chief Scientific Officer, Board member

Torbjörn Egelrud

Board member

Maria Klockare

Clinical Program Director

+5 flere kontakter i Funnelfeedr

Beskrivelse

Sixera Pharma is a small biopharmaceutical company established in Stockholm in 2013. The company originated from a project spun out of Swedish Orphan Biovitrum (Sobi) and Arexis. Their core mission is to develop their lead compound, SXR1096, into the first available treatment for Netherton syndrome....

Tags

B2BHealthcarePharmaceuticalsProfessional ServicesTechnologyWhite Collar

Nøgleord

BiotechnologyDrug DevelopmentNetherton SyndromeOrphan DrugRare Disease

Teknologistak

jQueryGoogle MapsPriority HintsWordPressVarnishJoomlaApache HTTP ServerPHPOpen GraphElementorYoast SEOGravatarWooCommerce

Virksomhedsoplysninger

Branche
Bioteknisk forskning och utveckling
Juridisk form
Aktiebolag
Momsnummer
SE556901476301

Beslutningstagere

9 kontakter i Funnelfeedr

Hans Olivecrona

Chief Medical Officer

Margit Mahlapuu

Chief Scientific Officer, Board member

Torbjörn Egelrud

Board member

Maria Klockare

Clinical Program Director

Jean Nordström

Founder

William Gunnarsson

Board member

Maarten de Château

Chief Executive Officer, Board member

Thomas Eldered

Board member

Lennart Hansson

Chairman of the Board

Lignende virksomheder

20 lignende virksomheder i Funnelfeedr

Udforsk mere

Spørgsmål om Sixera Pharma AB

Vil du se Funnelfeedr i aktion?

Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.

Book en demo